SAN DIEGO, CA / ACCESSWIRE / March 20, 2017 / Imprimis Pharmaceuticals, Inc. IMMY will host a conference call and live webcast to discuss the results of the fourth quarter and year end 2016, to be held Tuesday, March 21, 2017 at 4:30 PM Eastern Time.
Live Event Information
To participate, connect approximately 5 to 10 minutes before the beginning of the event.
- Date, Time: March 21, 2017 at 4:30 PM ET
- Toll Free: 877-407-8035
- International: 201-689-8035
- Live Webcast: www.investorcalendar.com/IC/CEPage.asp?ID=175578 or www.imprimisrx.com/
Replay Information
The replay will be available beginning approximately 2 hours after the completion of the live event, ending at midnight Eastern on April 21, 2017.
- Toll Free: 877-481-4010
- International: 919-882-2331
- Replay ID#: 10212
- Webcast: www.investorcalendar.com or www.imprimisrx.com/
About Imprimis Pharmaceuticals
Imprimis Pharmaceuticals, Inc. (IMMY) is a pharmaceutical company dedicated to producing and dispensing high quality innovative medications in all 50 states. The company's unique business model increases patient access and affordability to many critical medicines. Headquartered in San Diego, California, Imprimis owns and operates three production and dispensing facilities located in California, New Jersey, and Pennsylvania. For more information about Imprimis, please visit the corporate website at www.ImprimisRx.com.
SOURCE: Investor Network
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.